富士製薬工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4554/E00975 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/12/14 | 日証協 | 264,406株 | -0.9% | 33,100株 | -66.64% | 239,876株 | +8.02% | 40,903株 | +62.29% |
2018/12/07 | 日証協 | 266,806株 | -20.95% | 99,209株 | -58.12% | 222,076株 | -17.77% | 25,203株 | -17.64% |
2018/11/30 | 日証協 | 337,500株 | +0.9% | 236,906株 | +19.47% | 270,080株 | -0.7% | 30,600株 | +120.14% |
2018/11/22 | 日証協 | 334,500株 | +8.53% | 198,300株 | -3.36% | 271,980株 | -1.59% | 13,900株 | -60.06% |
2018/11/16 | 日証協 | 308,200株 | +1.62% | 205,203株 | -31.67% | 276,380株 | +3.56% | 34,800株 | +71.43% |
2018/11/09 | 日証協 | 303,300株 | +5.68% | 300,303株 | +40.27% | 266,880株 | +3.77% | 20,300株 | -48.08% |
2018/11/02 | 日証協 | 287,000株 | +12.68% | 214,094株 | -18.38% | 257,180株 | +19.46% | 39,100株 | -73.58% |
2018/10/26 | 日証協 | 254,700株 | +24.67% | 262,303株 | +50.98% | 215,280株 | +27.02% | 148,000株 | +643.72% |
2018/10/19 | 日証協 | 204,300株 | -24% | 173,733株 | +18.39% | 169,480株 | -23.89% | 19,900株 | -52.84% |
2018/10/12 | 日証協 | 268,800株 | -0.85% | 146,742株 | -38.09% | 222,680株 | +0.23% | 42,200株 | -40.49% |
2018/10/05 | 日証協 | 271,100株 | +127.82% | 237,036株 | +54.6% | 222,180株 | +59.81% | 70,908株 | +18.77% |
2018/09/28 | 日証協 | 119,000株 | +24.75% | 153,326株 | +17.44% | 139,026株 | +6.88% | 59,700株 | +103.75% |
2018/09/21 | 日証協 | 95,390株 | -50.03% | 130,561株 | +150.12% | 130,080株 | -22.61% | 29,300株 | +205.21% |
2018/09/14 | 日証協 | 190,890株 | +18.29% | 52,200株 | +11.78% | 168,080株 | +15.06% | 9,600株 | -43.53% |
2018/09/07 | 日証協 | 161,372株 | -8.19% | 46,700株 | -19.76% | 146,080株 | -7.12% | 17,000株 | +26.87% |
2018/08/31 | 日証協 | 175,772株 | -4.92% | 58,200株 | -28.68% | 157,280株 | -5.98% | 13,400株 | -36.19% |
2018/08/24 | 日証協 | 184,872株 | -11.08% | 81,600株 | +87.16% | 167,280株 | -0.24% | 21,000株 | +12.9% |
2018/08/17 | 日証協 | 207,900株 | -1.75% | 43,600株 | 0% | 167,680株 | +2.57% | 18,600株 | +48.73% |
2018/08/10 | 日証協 | 211,606株 | -2.04% | 0株 | -100% | 163,480株 | 0% | 12,506株 | -23.28% |
※株式分割は考慮していませんのでご注意ください。
Page Top